Dr. Annie De Groot will be in Japan from October 7th – 11th, to meet with collaborators and to host a semi-annual seminar on immunogenicity.
The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, tolerance induction).
Please check this page for updates.
To Confirm Your Attendence: Email Us Here
Westin Immunogenicity Seminar Seminar Osaka 2013
Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island (URI) & EpiVax, Inc.
Venue: The Westin Osaka
Tuesday, October 8th, 9:00 am – 5:00 pm
4th Floor Sara Room and Lunch is 4th Floor Kikyo Room
Lunch is provided
1-1-2 0 Oyodonaka, Kita Ward, Osaka, Osaka Prefecture 531-0076, Japan
Dr. Keizo Yoshida, PhD.
EpiVax Asia
Prof. Annie De Groot, M.D.
Professor and Director, Institute of Immunology and Informatics,
University of Rhode Island, CEO/CSO, EpiVax
Prof. Shimon Sakaguchi, M.D., Ph.D
Principal Investigator
Immunology (Immunological tolerance and autoimmune disease)
Osaka University
Prof. David W. Scott, PhD
Professor of Medicine
Vice Chair for Research
Department of Medicine (MED)
Uniformed Services University of Health Sciences
Prof. Ken Ishii, M.D., Ph.D
Project Leader
National Institute of Biomedical Innovation
Professor, PI
Laboratory of Vaccine Science, Osaka University
Please check this site for up-to-date information on the Westin Immunogenicity Seminar Osaka 2013.
To Confirm Your Attendence: Email Us Here
